ISIS SOD1Rx

· Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISIS SOD1Rx, covering 2012-04-13 to 2012-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Activity Study of ISIS SOD1Rx to Treat Familial Amyotrophic Lateral Sclerosis (ALS) Caused by SOD1 Gene Mutations [Phase 1]

See pricing